Last reviewed · How we verify

NCT05889104

Effect of Progressive Loading Protocol on Bone Mineral Density

Completed NA Last updated 29 September 2023
What this trial tests

NA trial testing Randomization Program in Osteoporosis in 92 participants. Completed in 5 August 2023.

Timeline
1 June 2023
Primary endpoint
1 August 2023
5 August 2023

Quick facts

Lead sponsorImam Abdulrahman Bin Faisal University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment92
Start date1 June 2023
Primary completion1 August 2023
Estimated completion5 August 2023
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Imam Abdulrahman Bin Faisal University

Who can join

Adults 50 to 60, any sex, with Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study are to examine the effects of Progressive Loading Exercises Protocol on Bone Mineral Density in osteoporotic patient's well-being and quality of life before a fracture occurs in order to create remedies. In addition, the available data from health research and clinical studies on osteoporosis will be evaluated for their impact on patient well-being and quality of life, providing an up-to-date and comprehensive overview of evidence-based treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoporosis

Currently open trials in the same condition.

Other Imam Abdulrahman Bin Faisal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05889104.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing